SCHEMBL2148981

SCHEMBL2148981

CCCCOC1(c2ccccc2F)CN(C(=O)[C@](Cc2ccc(OC)cc2)(OC(N)=O)C(C)(C)C)C1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MC1R Q01726 7/20 0.40
MC4R P32245 6/20 0.40
CTSK P43235 1/20 0.36
KMT2A Q03164 4/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
MEN1 O00255 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RAB9A P51151 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
THRB P10828 1/20 0.31
CASR P41180 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2148833 0.91 MC1R (0.47) MC1RMC4RCTSKALDH1A1TSHR
SCHEMBL2148882 0.83 MC1R (0.40) MC1RMC4RALDH1A1LMNASMN1; SMN2
SCHEMBL2149100 0.81 MC1R (0.50) MC1RMC4RMAPT
SCHEMBL2149007 0.79 MC1R (0.37) MC1RMC4RALDH1A1L3MBTL1
Trifluoroacetic Acid SCHEMBL1310165 0.75 MC1R (0.49) MC1RMC4R
SCHEMBL1312669 0.74 GPR119 (0.39) MC1RMC4RMAPTSMN1; SMN2
SCHEMBL2148982 0.74 MC1R (0.57) MC1RMC4RKMT2AALDH1A1LMNA
SCHEMBL2148899 0.74 NPC1 (0.34) CTSKKMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL1310666 0.73 MC1R (0.47) MC1RMC4RCTSKKMT2AMAPT
SCHEMBL16445371 0.72 MC1R (0.62) MC1RMC4RKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342194-A1 OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2011-07-13 EP disclosed
WO-2010052253-A1 OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-05-14 WO disclosed